From preclinical and clinical drug development plans up to proof of concept
Aepodia provides clinical due diligence support for preclinical pharmacology data to phase II clinical data to evaluate the:
- pertinence of the available preclinical and clinical data;
- interpretation of the available compound information;
- level of quality and regulatory compliance; and
- robustness of the IP.
We present our results in a technical report that includes a SWOT analysis.
We draw on a network of consultants and experts in toxicology, preclinical drug metabolism, chemistry, GLP, GMP and more to ensure effective and complete due diligence.